Protease stabilized acylated insulin analogues

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9688737
APP PUB NO 20150210747A1
SERIAL NO

14684863

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel acylated insulin analoges exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analoges contain B25H and A14E or A14H.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NOVO NORDISK A/S

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoeg-Jensen, Thomas Klampenborg, DK 50 369
Jakobsen, Palle Vaerloese, DK 54 446
Kjeldsen, Thomas B Virum, DK 5 22
Kodra, Janos Tibor Copenhagen, DK 48 1333
Madsen, Peter Bagsvaerd, DK 117 1108
Tagmose, Tina Moeller Ballerup, DK 17 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00